Polymyalgia Rheumatica
📧 Sign up to get email alerts when something new happens for Polymyalgia Rheumatica.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Update: Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) [Phase 3]
Phase 3 study evaluating efficacy and safety of olokizumab in polymyalgia rheumatica is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Update: A Phase III Study of the Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica [Phase 3]
Phase III trial evaluating the efficacy and safety of olokizumab in polymyalgia rheumatica is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS [Phase 3]
Phase 3 trial on abatacept for early onset polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) [Phase 3]
Open-label, long-term safety study of secukinumab in polymyalgia rheumatica is active/not recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) [Phase 3]
An open-label, long-term safety study of secukinumab in polymyalgia rheumatica is being conducted in Phase 3. The trial is currently active …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
This clinical trial update describes a qualitative study assessing the severity and impact of rheumatic immune-related adverse events, such …
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR [Phase 1]
Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of intravenous secukinumab in patients with Giant Cell Arteritis or …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency [Phase 4]
Phase 4 clinical trial evaluating supplemental hydrocortisone during stress in patients with prednisolone-induced adrenal insufficiency; cur…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) [Phase 3]
Phase 3 trial comparing secukinumab to placebo, in combination with a glucocorticoid taper regimen, in patients with Polymyalgia Rheumatica …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of sarilumab for adults with early polymyalgia rheumatica; recruitment not ye…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
This clinical trial update describes a study funded by Hôpital NOVO investigating the association between sacroiliitis/axial spondyloarthrit…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse [Phase 3]
A Phase 3 clinical trial is testing whether rituximab reduces glucocorticoid exposure in polymyalgia rheumatica patients experiencing relaps…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed [Phase 3]
A Phase 3 trial evaluated whether rituximab can decrease glucocorticoid exposure in patients recently diagnosed with polymyalgia rheumatica …
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment [Phase 4]
Phase 4 clinical trial evaluating hydrocortisone versus placebo in patients with symptoms of adrenal insufficiency after stopping glucocorti…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Giant Cell Arteritis - Ways to Precision Medicine
A recruiting clinical trial at Würzburg University Hospital explores precision medicine approaches for Giant Cell Arteritis and Polymyalgia …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Treat-to-target Prednisolon Taper in Patients With Polymyalgia Rheumatica [NA]
This clinical trial is evaluating a treat-to-target prednisolone taper strategy in polymyalgia rheumatica; the study is currently active but…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica [Phase 3]
A Phase 3 trial to justify and evaluate whether adding baricitinib to corticosteroids improves outcomes versus corticosteroids alone in poly…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica [NA]
A clinical trial is planned to evaluate the efficacy and safety of Ivarmacitinib for polymyalgia rheumatica, with recruitment not yet starte…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica
This clinical trial update describes a study using novel imaging approaches to improve diagnosis and treatment strategies for Polymyalgia Rh…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
This clinical trial update describes an ongoing study aimed at improving diagnostics and monitoring for Polymyalgia Rheumatica, with Giant C…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
A pilot clinical study (THROPIQ) is evaluating whether thrombomodulin can help rule out giant cell arteritis in patients with polymyalgia rh…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)
This clinical trial update describes the rationale for the initial diagnosis and the evaluation of disease evolution in a cohort of patients…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica [Phase 3]
This is a Phase 3 clinical trial evaluating induction and tapering therapy with tofacitinib in combination with glucocorticoids for polymyal…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR) [Phase 1]
This clinical trial update reports the termination of a Phase 1 study evaluating prednisolone in combination with SPI-62 for polymyalgia rhe…